Scientists from Cambridge and Stanford universities have performed the research that shows breast cancer can be subcategorized into 11 separate types.

The hope is that by identifying the subtypes of breast cancer it could facilitate risk estimation of its reoccurrence, as various types have a difference chance of relapse. Some categories have a tendency of reoccurrence within 10 years after the initial diagnosis, while the others are not likely to come back. This becomes highly important as the findings could potentially ensure closer monitoring of those who are at the higher risk.

GCT has completed numerous cancer studies, including breast cancer clinical trials. We look forward to further promising updates on the research.


Source: Nature Journal